Case Studies

Hello, world!

1. Eribulin delays metastasis BUT not for too long, why? Download

2. Lymph node status is not a good marker for metastasis probability; why? Download

3. How do tumour cells survive in the blood? Download

4. Moving and growing cells exhibit different properties; how? Download

5. Companion Diagnostics: metastasis prediction in primary tumour patients. Download

6. Case study in drug repurposing, with clinical validation. Download

7. Identifying critical steps and novel targets. Download

8. Animal model that differentiates between proliferation and metastasis. Download

9. Safety Assessment of Approved Drugs on Primary Tumour Progression.Download

10. High throughput metastasis model in Drosophila. Download

11. Bedside To Bench : Our Discovery Approach Download

12. Bedside To Bench : Our Repurposing Approach Download

13. Bedside To Bench : Our Companion Diagnostics Download

1. Eribulin delays metastasis BUT not for too long, why? Download

2. Lymph node status is not a good marker for metastasis probability; why? Download

3. How do tumour cells survive in the blood? Download

4. Moving and growing cells exhibit different properties; how? Download

5. Companion Diagnostics: metastasis prediction in primary tumour patients.Download

6. Case study in drug repurposing, with clinical validation..Download

7. Identifying critical steps and novel targets.Download

8. Animal model that differentiates between proliferation and metastasis.Download

9. Safety Assessment of Approved Drugs on Primary Tumour Progression.Download

10. High throughput metastasis model in Drosophila.Download